NEKTAR THERAPEUTICS Insider Trading for September 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS for September 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | EASTHAM KARIN | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | EASTHAM KARIN | Director | Grant | A | 0.00 | 6,500 | 0 | 15,000 | 8.5 K to 15 K (+76.47 %) |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 6,500 | 0 | 188,250 | 181.8 K to 188.3 K (+3.58 %) |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Grant | A | 0.00 | 6,500 | 0 | 29,700 | 23.2 K to 29.7 K (+28.02 %) |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Grant | A | 0.00 | 6,500 | 0 | 151,583 | 145.1 K to 151.6 K (+4.48 %) |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Grant | A | 0.00 | 6,500 | 0 | 280,973 | 274.5 K to 281 K (+2.37 %) |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Grant | A | 0.00 | 6,500 | 0 | 24,750 | 18.3 K to 24.8 K (+35.62 %) |
| Sep 24 2019 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Sell | S | 20.24 | 2,250 | 45,540 | 18,250 | 20.5 K to 18.3 K (-10.98 %) |
| Sep 18 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 7.21 | 25,000 | 180,250 | 50,000 | |
| Sep 18 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 20.52 | 25,000 | 513,000 | 152,872 | 177.9 K to 152.9 K (-14.06 %) |
| Sep 18 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 7.21 | 25,000 | 180,250 | 177,872 | 152.9 K to 177.9 K (+16.35 %) |
| Sep 09 2019 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | P | 17.28 | 15,000 | 259,200 | 107,668 | 92.7 K to 107.7 K (+16.19 %) |